Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy and safety evaluation of pembrolizumab plus epacadostat, pembrolizumab monotherapy, and the EXTREME regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:37:13.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' which includes examples such as a person's general health condition or prior treatments. Additionally, the 'Eligibility Criteria Description' now provides specific inclusion and exclusion criteria for study participants.
    Difference
    13%
    Check dated 2024-05-22T21:17:05.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention being presented. This change may be related to medical and healthcare-related publications and documentation.
    Difference
    1.0%
    Check dated 2024-05-01T18:42:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.